The Customers of Galena Pharma Are Extremely Happy: High-Quality Products and Excellent Service!

April 15, 2025

At the beginning of the year, we conducted a customer satisfaction survey to understand our customers’ experiences working with us during 2024. Based on the survey, we are proud to announce that our customers are extremely happy with the collaboration and they are highly willing to recommend Galena Pharma to their networks!


Net Promoter Score:

NPS: 92 / 100
NPS results range from -100 to +100. With an outstanding result of 92, we are delighted and happy to continue our good work for our customers!


Results related to our key operations:

  • Product Quality: 4.6 / 5
  • Delivery Reliability: 4.5 / 5
  • Ease of Collaboration: 4.8 / 5
  • Service Speed: 4.8 / 5


In addition to these numerical results, we received excellent open feedback from our customers, especially related to our reliability and smooth collaboration.


Customer needs in focus

Since 1996, Galena Pharma has been committed to serving its customers in the best possible way. Customer needs and the principle of continuous development are at the core of everything we do. Our customer relationships are typically long-term partnerships, which is also a sign of excellent customer satisfaction.


We can respond quickly to changing customer and market needs and requirements without compromising the quality or compliance of our products. “Our professional and committed employees strives to build long-term and confidential customer relationships while also ensuring that processes proceed flexibly from the customer’s perspective” highlights CEO Alexej von Bagh the factors behind the results.

Galena Pharma is a GMP- and EU MDR -certified pharmaceutical company specializing in manufacturing and developing substance-based medical devices. Galena Pharma provides its own ready-to-market MDR-approved medical devices for in-licensing as private label products. Our focus indication areas are gastrointestinal, female intimate care, cough & cold, pain and skin care.

Stay connected with us on LinkedIn for the latest industry news and updates!

Katarina Lundh has been appointed as Business Development Director of Galena Pharma

August 7, 2025
Katarina Lundh will start in the position on 11.8.2025. She succeeds Atte Kukkonen, who will continue working with Galena Pharma as a member of board.
Galena Pharma logo next to skincare products on a teal background.

Meet Galena Pharma at Leading Industry Events

August 5, 2025
We’re excited to announce that Galena Pharma will be attending several networking and partnering events across Europe during the second half of 2025. This is a great opportunity to connect with our team in person, explore potential collaborations, and learn more about our innovative medical devices. Join us at the following events: PharmaSynergy OTC on September 24-25 in Rome, to the event page click here CPHI on October 28-30 in Frankfurt, to the event page click here euroPLX by RauCon on November 24-25 in Berlin, to the event page click here About Galena Pharma Galena Pharma is a GMP- and MDR-certified pharmaceutical company specializing in the development and manufacturing of substance-based medical devices. We offer ready-to-market, MDR-approved medical devices available for in-licensing as a private label product. Our key focus areas include Gastrointestinal health, Female intimate care, Cough & cold, Pain relief and Skin care. Let’s meet and discuss how we can success together! More information and meeting appointments: Hrvoje Pervan, Sales Director, Central Europe hrvoje.pervan (at) galena.fi

ISO 14001 Environmental Certificate is a Key Part of Operations of Galena Pharma

April 29, 2025
During the spring of 2025, operations of Galena Pharma were re-certified to comply with the ISO 14001 environmental management system. As a result of the certification audit, we are pleased to announce that our operations consider environmental aspects with an excellent manner, and our renewed ISO 14001 certificate is now valid until 2028.